Modification of the anchor residue to MHC class I augments CTL-inducing ability of epitope peptides derived from dengue virus NS3 protein

Dengue Bulletin

Volumn 30, Issue , 2006, Pages 171-176

  Masaki, Hideyuki ^a   Fuji, Yoshiki ^b,c   Irimajiri, Kiyohiro ^a   Munakata, Hiroshi ^a   Tomura, Takanori T ^a   Kurane, Ichiro ^b,c  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Binding motif; Cytotoxic T lymphocyte; Dengue virus; Epitope peptide; MHC class I

Indexed keywords

DENGUE VACCINE; EPITOPE; FREUND ADJUVANT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 3; PEPTIDE; PEPTIDE DEN1.3; PEPTIDE DEN1.3 9L; PEPTIDE DEN2.4; PEPTIDE DEN2.4 9L; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DRUG BINDING SITE; DRUG SCREENING; FEMALE; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN MODIFICATION; SEROTYPE; TARGET CELL;

DENGUE VIRUS; MUS;

EID: 34848843850     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Gotch F, Gallimore A, McMichael A. Cytotoxic T cells - protection from disease progression - protection from infection. Immunol Lett 1996 Jun;51(1-2):125-8.
2. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989;7:601-24.
3. d-restricted antigenic peptides share a simple binding motif. Exp Med 1991 Sep 1;174(3):603-12.
4. Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Sette A, Rosenberg SA, Kawakami Y. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. J Immunol 1996 Sep 15;157(6):2539-48.
5. Baratin M, Kayibanda M, Ziol M, Romieu R, Briand JP, Guiller JG, Viguier M. Amino acid modifications in the wild type sequence p53 232-240 overcome the poor immunogenicity of this self tumour epitope. J Pept Sci 2002 Jui;8(7):327-34.
6. Halstead SB. Epidemiolosy of dengue and dengue hemorrhagic fever. In: Gubler DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever. Oxon UK: CBA International; 1997. p. 23-44.
7. Thein S, Aung MM, Shwe TN, Aye M, Zaw A, Aye K, Aye KM, Aaskov J. Risk factors in dengue shock syndrome. Am J Trop Med Hyg 1997 May;56(5):566-72.
8. Spaulding AC, Kurane I, Ennis FA, Rothman AL. Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J Virol 1999 Jan;73(1):398-403.
9. Fujii Y, Masaki H, Tomura TT, Irimajiri K, Kurane I. Induction of cytotoxic T lymphocytes by immunization with dengue virus-derived, modified epitope peptide, using dendritic cells as a peptide delivery system. Dengue Bulletin 2004;28:145-50.
10. Bendelac A, Medzhitov R. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J Exp Med. 2002 Mar 4;195(5):F19-23.
11. Livingston PG, Kurane I, Dai LC, Okamoto Y, Lai CJ, Men R, Karaki S, Takiguchi M, Ennis FA. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol. 1995 Feb 1;154(3):1287-95.
12. Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol. 2002 Jun 1;168(11):5959-65.